United Therapeutics (UTHR) Debt Ratio (2010 - 2025)

United Therapeutics has disclosed Debt Ratio across 14 years of filings, most recently posting 0.03 for Q1 2025.

• Debt Ratio for Q1 2025 came in at 0.03, down 72.04% year-over-year; the trailing twelve-month figure through Mar 2025 was 0.03 (down 72.04% YoY), and the FY2024 annual result was 0.04, down 58.29% from the prior year.
• Debt Ratio came in at 0.03 for Q1 2025 at United Therapeutics, down from 0.04 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.17 in Q1 2021 to a low of 0.03 in Q1 2025.
• The 5-year median for Debt Ratio is 0.13 (2023), against an average of 0.12.
• Across the five-year window, Debt Ratio retreated 10.72% in 2021 and sank 72.04% in 2025, its largest moves.
• United Therapeutics' Debt Ratio stood at 0.15 in 2021, then fell by 14.48% to 0.13 in 2022, then fell by 26.2% to 0.1 in 2023, then tumbled by 58.29% to 0.04 in 2024, then sank by 36.6% to 0.03 in 2025.
• The last three Debt Ratio figures came in at 0.03 (Q1 2025), 0.04 (Q4 2024), and 0.06 (Q3 2024), per Business Quant data.